Lipid tucaresol as an adjuvant for methamphetamine vaccine development

被引：23
|
作者：
Collins, K. C. [1 ,2 ,3 ]
Schlosburg, J. E. [1 ,2 ,3 ,4 ]
Lockner, J. W. [1 ,2 ,3 ]
Bremer, P. T. [1 ,2 ,3 ]
Ellis, B. A. [1 ,2 ,3 ]
Janda, K. D. [1 ,2 ,3 ]
机构：
[1] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, WIRM, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol, Skaggs Inst Chem Biol, WIRM, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Microbial Sci, Skaggs Inst Chem Biol, WIRM, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA
来源：
CHEMICAL COMMUNICATIONS | 2014年 / 50卷 / 31期
关键词：
IMMUNIZATION; LIPOSOMES; HAPTEN; SYSTEM; IMPACT;
D O I：
10.1039/c4cc00682h
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The immunopotentiator tucaresol was modified for incorporation into liposomes, where it was found to be a superior adjuvant to MPLA for vaccination against methamphetamine.
引用
收藏
页码：4079 / 4081
页数：3
相关论文
共 50 条
  • [21] Chemically Synthesized Alcaligenes Lipid A as an Adjuvant to Augment Immune Responses to Haemophilus Influenzae Type B Conjugate Vaccine
    Liu, Zilai
    Hosomi, Koji
    Shimoyama, Atsushi
    Yoshii, Ken
    Sun, Xiao
    Lan, Huangwenxian
    Wang, Yunru
    Yamaura, Haruki
    Kenneth, Davie
    Saika, Azusa
    Nagatake, Takahiro
    Kiyono, Hiroshi
    Fukase, Koichi
    Kunisawa, Jun
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
    Lu, Lu
    Fong, Carol Ho-Yan
    Zhang, Anna Jinxia
    Wu, Wai-Lan
    Li, Iris Can
    Lee, Andrew Chak-Yiu
    Dissanayake, Thrimendra Kaushika
    Chen, Linlei
    Hung, Ivan Fan-Ngai
    Chan, Kwok-Hung
    Chu, Hin
    Kok, Kin-Hang
    Yuen, Kwok-Yung
    To, Kelvin Kai-Wang
    VACCINES, 2020, 8 (04) : 1 - 17
  • [23] The use of propolis as vaccine's adjuvant
    El Ashry, El Sayed H.
    Ahmad, Tarek A.
    VACCINE, 2012, 31 (01) : 31 - 39
  • [24] Vaccine Adjuvant Properties of Probiotic Bacteria
    Licciardi, Paul V.
    Tang, Mimi L. K.
    DISCOVERY MEDICINE, 2011, 12 (67) : 525 - 533
  • [25] EFFECT OF DETOX AS AN ADJUVANT FOR MELANOMA VACCINE
    SCHULTZ, N
    ORATZ, R
    CHEN, DL
    ZELENIUCHJACQUOTTE, A
    ABELES, G
    BYSTRYN, JC
    VACCINE, 1995, 13 (05) : 503 - 508
  • [26] A mucosal adjuvant for the inactivated poliovirus vaccine
    Steil, Benjamin P.
    Jorquera, Patricia
    Westdijk, Janny
    Bakker, Wilfried A. M.
    Johnston, Robert E.
    Barro, Mario
    VACCINE, 2014, 32 (05) : 558 - 563
  • [27] Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design
    Gooyit, Major
    Miranda, Pedro O.
    Wenthur, Cody J.
    Ducime, Alex
    Janda, Kim D.
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (03): : 468 - 472
  • [28] Development of a Modular NTA:His Tag Viral Vaccine for Co-delivery of Antigen and Adjuvant
    Chung, Young Hun
    Volckaert, Britney A.
    Steinmetz, Nicole F.
    BIOCONJUGATE CHEMISTRY, 2023, 34 (01) : 269 - 278
  • [29] Development and Evaluation of the Biological Adjuvant Bivalent Vaccine for Preventing Newcastle Disease and Infectious Bursal Disease
    Guo, Xiaochen
    Sun, Wenying
    Hu, Changhui
    Wang, Xiangxiang
    Li, Shuang
    Qin, Ruihan
    Wang, Yixuan
    Liu, Jinmiao
    Xue, Zhiqiang
    Li, Huijuan
    Zhang, Tingting
    Wang, Wei
    Guo, Yunpeng
    Yin, Jiechao
    Jiang, Ming
    Zhao, Han
    Wei, Lan
    Zhang, Jingmin
    Ren, Guiping
    TRANSBOUNDARY AND EMERGING DISEASES, 2023, 2023
  • [30] Key steps in vaccine development
    Stern, Peter L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (01) : 17 - 27
12345